Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michela Benvenuti"'
Autor:
Elena Braghieri, Emilio Terlizzi, Michela Benvenuti, Maria Teresa Pinotti, Roberto Antenucci, Marcello Sartori, Massimo Esposito, Rossella Raggi
This article introduces the report on the difference occurred in management of ALS patients by an italian Public Health Care Service through 15 years with-and without DTCP (Diagnostic and Therapeutic Care Pathway) during three timeframes. The article
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfc655a95270682e3da43ce103e2da5b
https://doi.org/10.21203/rs.3.rs-540129/v1
https://doi.org/10.21203/rs.3.rs-540129/v1
Autor:
Enza Barbieri, Natalia Calonghi, Elisa Zuffa, Gianluca Brusa, Michela Benvenuti, Maria Alessandra Santucci, Manuela Mancini
Publikováno v:
British Journal of Haematology. 132:359-369
The BCR-ABL fusion gene, originating from the balanced (9;22) translocation, is the molecular hallmark and the causative event of chronic myeloid leukaemia (CML). The interactions of its p210 protein constitutively activated and improperly confined t
Autor:
Gianluca Brusa, Giovanni Martinelli, Maria Alessandra Santucci, Michela Benvenuti, Michele Baccarani, Manuela Mancini, Lucia Mazzacurati, Laura Pattacini
Publikováno v:
Leukemia Research. 28:191-202
The endoplasmic reticulum (ER) is the site where proteins destined to either secretion or different subcellular compartments assemble and the major storage of intracellular Ca 2+ . The ER stress resulting from a variety of toxic insults leads to apop
Autor:
Maria Alessandra Santucci, Gianluca Brusa, Lucia Mazzacurati, Michela Benvenuti, Michele Baccarani, Giovanni Martinelli, Laura Pattacini, Joel S. Greenberger, Enza Barbieri, Manuela Mancini
Publikováno v:
The Hematology Journal. 5:168-177
STI571 is the most innovative drug for the cure of Chronic Myeloid Leukemia. It inhibits, in fact, the disease causative event, the p210 bcr-abl tyrosine kinase, and addresses clonal myeloid progenitors to apoptotic death. Here, we demonstrated that
Autor:
Maria Alessandra Santucci, F. Campanini, Enza Barbieri, Manuela Mancini, Michela Benvenuti, Giovanni Martinelli, Gianluca Brusa, Michele Baccarani, Silvia Cammelli, Lucia Mazzacurati, Natalia Calonghi
Publikováno v:
Leukemia. 18:370-372
The p210 BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene
Autor:
Gianluca, Brusa, Elisa, Zuffa, Manuela, Mancini, Michela, Benvenuti, Natalia, Calonghi, Enza, Barbieri, Maria Alessandra, Santucci
Publikováno v:
British journal of haematology. 132(3)
The BCR-ABL fusion gene, originating from the balanced (9;22) translocation, is the molecular hallmark and the causative event of chronic myeloid leukaemia (CML). The interactions of its p210 protein constitutively activated and improperly confined t
Autor:
Gianluca, Brusa, Michela, Benvenuti, Lucia, Mazzacurati, Manuela, Mancini, Laura, Pattacini, Giovanni, Martinelli, Enza, Barbieri, Joel S, Greenberger, Michele, Baccarani, Maria Alessandra, Santucci
Publikováno v:
Haematologica. 88(6)
The p210 bcr-abl fusion protein has a key role in the pathogenesis of chronic myeloid leukemia (CML). However, its influence on disease progression to blast crisis is marginal and mostly due to its effect of impairing the genomic stability of clonal